Ledger.Open graph →
SEC Form D · filed November 2, 2012

ACCESS PHARMACEUTICALS INC

Offering
$10.0M
Sold
$10.0M
Exemption
Industry
Pharmaceuticals
Location
DALLAS, TX
Type

People & firms on this filing (11)

Steven H. Rouhandeh · Dallas, TXDirectorStephen B. Howell, M.D · Dallas, TXDirectorMark J. Alvino · Dallas, TXDirectorJeffrey B. Davis · Dallas, TXExec · DirectorMark J. Ahn, Ph.D · Dallas, TXDirectorRobin Felder · Glen Allen, VAExec · DirectorJohn Maynard · Toronto, Ontario, CanadaDirectorGregory Boland · Toronto, Ontario, CanadaDirectorPaul D. Kazilionis · Palm Beach Gardens, FLDirectorWestLane Capital Management, LLC · Stamford, CTDirectorStephen B. Thompson · Dallas, TXExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗